Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2018-04-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
内部控制规则落实自查表
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制规则落实自查表" which translates to "Internal Control Rules Implementation Self-Inspection Form." It contains detailed internal control checklists related to internal audit operations, information disclosure, insider trading controls, fundraising, related party transactions, external guarantees, major investments, and other important matters. The document is a self-assessment or internal control checklist rather than a financial report or announcement. It does not contain financial statements, earnings data, or regulatory filings such as audit reports or annual reports. It is also not an announcement or presentation. The content is focused on internal control compliance and audit-related internal procedures, which aligns best with an Audit Report / Information (AR) category, as it relates to internal audit and control results but is not a full annual report or earnings release. The document length is 3629 characters, which is relatively short but contains substantive internal control information rather than just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2017
2018-04-25 Chinese
第五届监事会第十八次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 18th meeting of the 5th Supervisory Board of 嘉事堂药业股份有限公司. It includes approvals of various reports such as the 2017 Supervisory Board Work Report, 2017 Business Summary, 2017 Internal Control Self-Evaluation Report, 2017 Financial Statements, 2017 Profit Distribution Plan, 2017 Annual Report and its summary, 2017 Social Responsibility Report, and other related reports. The document also references that these reports are available elsewhere (e.g., on the 巨潮资讯网 website) and that they require shareholder approval. The document itself is not the full annual report but a meeting resolution announcement regarding these reports. Given the content and nature, this fits best under Regulatory Filings (RNS) as it is a regulatory announcement of supervisory board meeting resolutions and approvals, not the full annual report or other standalone reports themselves. The document length is 3153 characters, which is relatively short and consistent with an announcement rather than a full report.
2018-04-25 Chinese
2017年年度报告
Annual Report Classification · 100% confidence The document is titled as the full 2017 annual report of 嘉事堂药业股份有限公司 (Cachet Pharmaceutical Co., Ltd.). It contains detailed sections typical of an annual report, including company overview, financial data, business analysis, management discussion, and financial statements. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes comprehensive financial figures, business operations, acquisitions, and governance information for the fiscal year 2017. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2017
2018-04-25 Chinese
独立董事关于第五届董事会第二十三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various company matters related to the fifth board meeting of 嘉事堂药业股份有限公司. It includes independent opinions on the 2017 audit report, internal control self-evaluation report, related party transactions, use of raised funds, expected related party transactions for 2018, profit distribution proposal, and accounting policy changes. The document references the 2017 audit report and internal control report but does not contain the full audit report or detailed financial statements itself. It is a formal opinion letter from independent directors on board meeting matters, which aligns with Board/Management Information filings rather than a full audit report or annual report. The document length is 2749 characters, relatively short and focused on opinions rather than full financial data. Therefore, the best classification is Board/Management Information (MANG).
2018-04-25 Chinese
关联方占用资金情况的专项审计说明（2017年度）
Audit Report / Information Classification · 95% confidence The document is a specialized audit report concerning the 2017 non-operating funds occupied and other related party fund transactions of 嘉事堂药业股份有限公司. It includes an auditor's opinion, references to regulatory requirements from the China Securities Regulatory Commission, and detailed financial tables about related party transactions. The document is titled as a '专项审计说明' (special audit explanation) and contains audit procedures, responsibilities, and an audit opinion. It is not a full annual report but a standalone audit report focused on a specific issue related to related party transactions and fund occupation. The document length is 4639 characters, which is sufficient for a detailed audit report but not a full annual report. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2017
2018-04-25 Chinese
2017年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告及财务报表" which translates to "Audit Report and Financial Statements" for the fiscal year 2017. It contains detailed audit opinions, key audit matters, and extensive financial statements including consolidated and company balance sheets, profit and loss statements, and cash flow statements. The presence of an auditor's opinion, detailed audit procedures, and comprehensive financial data confirms this is a standalone audit report with accompanying financial statements, not a full annual report or just an announcement. The document length is substantial (15,000 characters) and contains actual financial data and audit details, so it is not a mere announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2017
2018-04-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.